Literature DB >> 24267852

Evidence-based intervention for chronic refractory breathlessness: practical therapies that make a difference.

David Currow1, Miriam Johnson, Patrick White, Amy Abernethy.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24267852      PMCID： PMC3809422          DOI： 10.3399/bjgp13X674611

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  8 in total

Review 1.  A systematic review of the use of opioids in the management of dyspnoea.

Authors:  A-L Jennings; A N Davies; J P T Higgins; J S R Gibbs; K E Broadley
Journal:  Thorax       Date:  2002-11       Impact factor: 9.139

Review 2.  Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease.

Authors:  Hope Uronis; Douglas C McCrory; Gregory Samsa; David Currow; Amy Abernethy
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15

3.  Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial.

Authors:  Amy P Abernethy; Christine F McDonald; Peter A Frith; Katherine Clark; James E Herndon; Jennifer Marcello; Iven H Young; Janet Bull; Andrew Wilcock; Sara Booth; Jane L Wheeler; James A Tulsky; Alan J Crockett; David C Currow
Journal:  Lancet       Date:  2010-09-04       Impact factor: 79.321

4.  Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study.

Authors:  David C Currow; Christine McDonald; Sheila Oaten; Bernadette Kenny; Peter Allcroft; Peter Frith; Michael Briffa; Miriam J Johnson; Amy P Abernethy
Journal:  J Pain Symptom Manage       Date:  2011-03-31       Impact factor: 3.612

5.  Dyspnea in the advanced cancer patient.

Authors:  D J Dudgeon; M Lertzman
Journal:  J Pain Symptom Manage       Date:  1998-10       Impact factor: 3.612

Review 6.  Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases.

Authors:  C Bausewein; S Booth; M Gysels; I Higginson
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16

7.  Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea.

Authors:  Amy P Abernethy; David C Currow; Peter Frith; Belinda S Fazekas; Annie McHugh; Chuong Bui
Journal:  BMJ       Date:  2003-09-06

Review 8.  Oxygen for relief of dyspnoea in mildly- or non-hypoxaemic patients with cancer: a systematic review and meta-analysis.

Authors:  H E Uronis; D C Currow; D C McCrory; G P Samsa; A P Abernethy
Journal:  Br J Cancer       Date:  2008-01-08       Impact factor: 7.640
  8 in total
  4 in total

1.  Should we measure dyspnoea in everyone?

Authors:  Robert B Banzett; Carl R O'Donnell
Journal:  Eur Respir J       Date:  2014-06       Impact factor: 16.671

Review 2.  End-of-life care in patients with advanced lung cancer.

Authors:  Richard B L Lim
Journal:  Ther Adv Respir Dis       Date:  2016-09-01       Impact factor: 4.031

3.  Application of Evidence-Based Nursing Intervention in the Treatment of Advanced Squamous Cell Carcinoma of the Lung by Erlotinib Combined with Tegafur, Gimeracil, and Oteracil Potassium and Its Influence on Quality of Life.

Authors:  Shan Liu; Xiaocheng Huang; Jin Wen; Fangfang Fu; Huifen Wang
Journal:  J Healthc Eng       Date:  2021-12-13       Impact factor: 2.682

Review 4.  Advanced Chronic Obstructive Pulmonary Disease: Innovative and Integrated Management Approaches.

Authors:  Hai-Xia Zhou; Xue-Mei Ou; Yong-Jiang Tang; Lan Wang; Yu-Lin Feng
Journal:  Chin Med J (Engl)       Date:  2015-11-05       Impact factor: 2.628
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.